Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.99 USD | +1.12% | +5.58% | +12.94% |
Jun. 21 | Morgan Stanley Adjusts Price Target on Centessa Pharmaceuticals to $11 From $8, Maintains Equalweight Rating | MT |
Jun. 10 | Centessa Pharmaceuticals Appoints John Crowley as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.94% | 1B | |
+23.13% | 52.73B | |
+37.49% | 39B | |
-8.73% | 38.52B | |
+28.09% | 30.38B | |
-12.26% | 26.39B | |
+10.57% | 26.08B | |
+45.05% | 14.15B | |
+32.23% | 12.6B | |
-6.56% | 11.51B |
- Stock Market
- Equities
- CNTA Stock
- News Centessa Pharmaceuticals plc
- Morgan Stanley Adjusts Price Target on Centessa Pharmaceuticals to $11 From $8, Maintains Equalweight Rating